Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Dyne Therapeutics, Inc. | CEO & President, Director | Common Stock | 8K | $265K | $33.09 | Sep 4, 2024 | By Trust #1 |
Dyne Therapeutics, Inc. | CEO & President, Director | Common Stock | 8K | $265K | $33.09 | Sep 4, 2024 | By Trust #2 |
Dyne Therapeutics, Inc. | CEO & President, Director | Common Stock | 8K | $265K | $33.09 | Sep 4, 2024 | By Trust #3 |
Dyne Therapeutics, Inc. | CEO & President, Director | Common Stock | 8K | $265K | $33.09 | Sep 4, 2024 | By Trust #4 |
Dyne Therapeutics, Inc. | CEO & President, Director | Common Stock | 5K | $165K | $33.09 | Sep 4, 2024 | Direct |
Dyne Therapeutics, Inc. | CEO & President, Director | Stock Option (Right to Buy) | 680K | Mar 25, 2024 | Direct | ||
Sigilon Therapeutics, Inc. | Director | Common Stock | 0 | Aug 11, 2023 | Direct | ||
Sigilon Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | $0.75 | Aug 11, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
DYN | Dyne Therapeutics, Inc. | Sep 4, 2024 | 8 | $1.06M | 4 | Sep 4, 2024 | CEO & President, Director |
DYN | Dyne Therapeutics, Inc. | Mar 25, 2024 | 0 | $0 | 3/A | Apr 4, 2024 | CEO & President, Director |
DYN | Dyne Therapeutics, Inc. | Mar 25, 2024 | 1 | $0 | 4 | Mar 27, 2024 | Chief Executive Officer and President, Director |
DYN | Dyne Therapeutics, Inc. | Mar 25, 2024 | 0 | $0 | 3 | Mar 27, 2024 | Chief Executive Officer and President Exhibit Index: 24.1 Power of Attorney, Director |
SGTX | Sigilon Therapeutics, Inc. | Aug 11, 2023 | 3 | -$7.95K | 4 | Aug 11, 2023 | Director |
SGTX | Sigilon Therapeutics, Inc. | May 19, 2023 | 1 | $0 | 4 | May 22, 2023 | Director |
SGTX | Sigilon Therapeutics, Inc. | May 26, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
SGTX | Sigilon Therapeutics, Inc. | Jun 24, 2021 | 1 | $88.6K | 4 | Jun 28, 2021 | Director |